INNOLIFE CO LTD has a total of 43 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2015. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Hong Kong. Its main competitors in its focus markets pharmaceuticals are CM & D PHARMA LTD, PROBIONOV and MICO BIO INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Hong Kong | 3 | |
#4 | Republic of Korea | 3 | |
#5 | Australia | 2 | |
#6 | Brazil | 2 | |
#7 | Canada | 2 | |
#8 | Chile | 2 | |
#9 | Colombia | 2 | |
#10 | Ecuador | 2 | |
#11 | EPO (European Patent Office) | 2 | |
#12 | Israel | 2 | |
#13 | Mexico | 2 | |
#14 | New Zealand | 2 | |
#15 | Peru | 2 | |
#16 | United States | 2 | |
#17 | EAPO (Eurasian Patent Organization) | 1 | |
#18 | Japan | 1 | |
#19 | Singapore | 1 | |
#20 | Taiwan | 1 | |
#21 | Ukraine | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Kang Yujian James | 34 |
#2 | Yujian James Kang | 4 |
#3 | Kang Yujian | 2 |
#4 | Kang Yu Jian James | 1 |
Publication | Filing date | Title |
---|---|---|
CN111297895A | Pharmaceutical use of composition for treating atherosclerosis | |
WO2017049529A1 | A pharmaceutical composition comprising a copper chelating tetramine and the use thereof | |
WO2016168993A1 | Methods of tissue repair and regeneration |